Michael P Mullen, MD
- PROFESSOR | Medicine, Infectious Diseases
- DIRECTOR INSTITUTE FOR ADVANCED MEDICINE
Specialties:Infectious Disease, Internal Medicine
In the NewsDr. Mullen talks about the ongoing struggle against AIDS, treatment improvements, and new drugs in e Daily News feature "The Daily Check Up."
View the PDF.
American Board of Internal Medicine
MD, Universidad de Navarra
Residency, Internal Medicine, Interfaith Medical Center
Fellowship, Infectious Disease, Cabrini Medical Center [CLOSED]
- A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/ Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults
The purpose of this research study is to see if an investigational combination medication Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single Tablet Regimen (E/C/F/TAF STR) is safe and effective in reducing levels of HIV-1 in the blood of subjects who are treatm...